Saizen Therapy Enhances Growth in American Males with Spinal Muscular Atrophy
Reading Time: 3 minutesIntroduction Spinal Muscular Atrophy (SMA) is a genetic disorder characterized by the progressive loss of motor neurons, leading to muscle weakness and atrophy. This condition significantly impacts the growth and development of affected children. Saizen, a recombinant human growth hormone, has been explored as a potential therapeutic option to improve growth outcomes in these patients. This article delves into the... Read more »